Ondansetron Orally Disintegrating Tablet

Get a Price/Quote

MOQ : 1 , , Unit

Ondansetron Orally Disintegrating Tablet Specification

Origin of Medicine
Allopathic

Salt Composition
Ondansetron

Indication
Prevention and treatment of nausea and vomiting

Pacakaging (Quantity Per Box)
As per commercial packaging, commonly 10 tablets per strip, several strips per box

Dosage Form
Orally Disintegrating Tablet (ODT)

Drug Type
General Medicines

Ingredients
Ondansetron

Physical Form
Tablets

Function
Antiemetic

Recommended For
Nausea and vomiting control

Dosage
As directed by physician

Dosage Guidelines
Orally, allow to disintegrate on the tongue before swallowing

Suitable For
Adults and children

Quantity
Available in various pack sizes

Storage Instructions
Store in a cool, dry place away from sunlight

Excipients
May contain mannitol, aspartame, microcrystalline cellulose, citric acid, magnesium stearate (composition may vary)

Color
White to off-white

Method of Administration
Oral use only, disintegrates rapidly in the mouth without water

Shape
Round, flat tablets

Strength
Common strengths available: 4 mg, 8 mg

Warning
To be used under medical supervision

Contraindications
Known hypersensitivity to Ondansetron or any excipients

Shelf Life
24-36 months from date of manufacture

Regulatory Status
Prescription only

Ondansetron Orally Disintegrating Tablet About

Used to treat high blood pressure Joytel - AM Tablets, these are formulated with telmisartan and amlodipine in adherence with the set medical industry norms in the processing process. To meet various requirements of clients we offer this product in various packaging options. Telmisartan is an angiotensin receptor blocker (ARB) and amlodipine is a calcium channel blocker. Joytel - AM Tablets works by relaxing the blood vessels which lowers blood pressure and improves blood flow.

Effortless Administration for Fast Relief

Ondansetron Orally Disintegrating Tablets dissolve swiftly on the tongue, making them an excellent choice for patients who find it difficult to swallow conventional tablets or require antiemetic therapy without water. The ease of administration enhances comfort, particularly during episodes of nausea and vomiting.

Safe and Effective Nausea Control

Specially formulated to prevent and treat nausea and vomiting, these tablets are suitable for adults and children. Their antiemetic action provides reliable symptom relief as directed by a physician, helping patients maintain a sense of well-being during recovery or ongoing treatments.

Quality Assurance and Storage

Manufactured under strict standards in India, each batch of tablets meets regulatory requirements for prescription medication. They offer a shelf life of up to 36 months and should be stored in a cool, dry place, away from sunlight, to preserve their efficacy.

FAQs of Ondansetron Orally Disintegrating Tablet:

Q: How should I take Ondansetron Orally Disintegrating Tablet?

A: Place the tablet on your tongue and allow it to fully disintegrate before swallowing; water is not required. Always take the medicine exactly as directed by your physician.

Q: What is the benefit of using the orally disintegrating form of Ondansetron?

A: The orally disintegrating tablet provides rapid onset of action and convenient administration, especially for patients experiencing nausea and those who may have difficulty swallowing conventional tablets.

Q: When is Ondansetron Orally Disintegrating Tablet recommended?

A: This medicine is prescribed for the prevention and treatment of nausea and vomiting caused by medical conditions, chemotherapy, or surgery, as determined by a healthcare provider.

Q: Where should I store Ondansetron tablets for maximum shelf life?

A: Store the tablets in a cool, dry environment away from direct sunlight to ensure they remain effective for their full shelf life of 2436 months.

Q: What precautions should be considered before using this medication?

A: Ondansetron should only be used under medical supervision. It is contraindicated in individuals with known hypersensitivity to Ondansetron or any of its excipients.